Streamline Antimicrobial Gene Expression With a Microfluidics Approach

Amoebic gill disease, caused by the parasite Neoparamoeba perurans, poses significant health challenges to Atlantic salmon, leading to significant economic losses. Hence, in the dynamic field of aquaculture, understanding fish immunology is crucial for disease management. However, analysis of antimicrobial peptides (AMP) can be challenging, as traditional techniques are labor-intensive and expensive. This webinar explores a microfluidics approach to quantify AMP gene expression, providing insights into potential biomarkers for early disease detection and improved treatment strategies. Watch this webinar to discover: • The impact of microfluidics technology on the efficiency and reliability of gene expression studies in aquaculture • The role of AMP in fishes’ defense against pathogens • Potential use of AMPs as biomarkers for early detection of amoebic gill disease